Synergistic induction of in vivo angiogenesis by the combination of insulin-like growth factor-II and epidermal growth factor

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 843-848

  Lee, You Mie ^a   Bae, Myung Ho ^b   Lee, Ok Hee ^a   Moon, Eun Joung ^a   Moon, Chang Kiu ^a   Kim, Woo Ho ^a   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

^b Yuhan Research Institute   (South Korea)

Author keywords

Angiogenesis; EGF; IGF II; In vivo; Synergism

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; LAMININ; MATRIGEL; MESSENGER RNA; PROTEOGLYCAN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL; ANOXIA; ARTICLE; BLOOD VESSEL; C57BL MOUSE; CANCER INVASION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CHICK EMBRYO; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MOUSE; PATHOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANOXIA; BLOOD VESSELS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; CHICK EMBRYO; COLLAGEN; DRUG COMBINATIONS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR II; LAMININ; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RNA, MESSENGER; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 16644377280     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.843     Document Type: Article

References (21)

1. Hanahan D and Folkman J: Patterns and emerging mechanism of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996. (Pubitemid 26272076)
2. Ferrara N and Alitalo K: Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5: 1359-1364, 1999.
3. Kim KW, Bae SK, Lee OH, Bae MH, Lee MJ and Park BC: Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58: 348-351, 1998.
4. Volpert O, Jackson D, Bouck N and Linzer DI: The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 137: 3871-3786, 1996.
5. Bae MH, Lee MJ, Bae SK, Lee OH, Lee YM, Park BC and Kim KW: Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Lett 128: 41-46, 1998. (Pubitemid 28279363)
6. Motoo Y, Sawabu N and Nakanuma Y: Expression of epidermal growth factor and fibroblast growth factor in human hepatocellular carcinoma: an immunohistochemical study. Liver 11: 272-277, 1991.
7. Hisaka T, Yano H, Haramaki M, Utsunomiya I and Kojiro M: Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation. Int J Oncol 14: 453-460, 1999.
8. Hamazaki K, Yunoki Y, Tagashira H, Mimura T, Mori M and Orita K: Epidermal growth factor receptor in human hepatocellular carcinoma. Cancer Detect Prev 21: 355-360, 1997. (Pubitemid 27335556)
9. Wraight CJ and Werther GA: Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J Invest Dermatol 105: 602-607, 1995.
10. Frystyk J, Vinter-Jensen L, Skjaerbaek C and Flyvbjerg A: The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats. Growth Regul 6: 48-54, 1996. (Pubitemid 26139234)
11. Hembree JR, Agarwal C and Eckert RL: Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1. Cancer Res 54: 3160-3166, 1994.
12. Steller MA, Delgado CH and Zou Z: Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells. Proc Natl Acad Sci USA 92: 11970-11974, 1995. (Pubitemid 26013992)
13. Kim YM, Kim YM, Lee YM, Kim HS, Kim JD, Choi Y, Kim KW, Lee SY and Kwon YG: TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 277: 6799-6805, 2002. (Pubitemid 34953061)
14. Yamamura S, Nelson PR and Kent KC: Role of protein kinase C in attachment, spreading, and migration of human endothelial cells. J Surg Res 63: 49-354, 1996.
15. Herron GS, Banda MJ, Clark EJ, Gavrilovic J and Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261: 2814-2818, 1986. (Pubitemid 17218297)
16. Lee OH, Bae SK, Bae MH, Lee YM, Moon EJ, Cha HJ, Kwon YG and Kim KW: Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 82: 385-391, 2000. (Pubitemid 30045386)
17. Valentinis B, Bhala A, De Angelis T, Baserga R and Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9: 361-367, 1995.
18. Menuelle P, Binoux M and Pias C: Regulation by insulin-like growth factor (IGF) binding proteins of IGF-II-stimulated glycogenesis in cultured fetal rat hepatocytes. Endocrinology 136: 5305-5310, 1995.
19. Mohan S, Bautista CM, Wergedal J and Baylink DJ: Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci USA 86: 8338-8342, 1989. (Pubitemid 19286055)
20. Ross M, Francis GL, Szabo L, Wallace JC and Ballard FJ: Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(1-3)-IGF-I. Biochem J 258: 267-272, 1989. (Pubitemid 19062278)
21. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P and Cao Y: Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9: 604-613, 2003. (Pubitemid 36597108)